Download PDF
Thromb Haemost 1979; 42(04): 1340-1343
DOI: 10.1055/s-0038-1657030
Letter to the Editor
Schattauer GmbH Stuttgart

Prostacyclin Analogs: Antiaggregatory Potency and Enhancement of cAMP Levels in Human Platelet Rich Plasma

A Dembinska-Kiec
Zentrum für Pharmakologie u. Toxikologie, Medizinische Hochschule Hannover, D-3000 Hannover 61, Fed. Rep. Germany
,
W Rücker
Zentrum für Pharmakologie u. Toxikologie, Medizinische Hochschule Hannover, D-3000 Hannover 61, Fed. Rep. Germany
,
P S Schönhöfer
Zentrum für Pharmakologie u. Toxikologie, Medizinische Hochschule Hannover, D-3000 Hannover 61, Fed. Rep. Germany
,
C Gandolfi
Farmitalia Carlo Erba, Via Carlo Imbonati 24, 1-20159 Milan/Italy
› Author Affiliations
Further Information

Publication History

Publication Date:
23 August 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Gilman AG. 1970; A protein binding assay for adenosine-3’, 5’-cyclic monophosphate. Proc. Nat. Acad. Sci. USA 67: 305
    CrossrefPubMedSearch in Google Scholar
  • 2 Gorman RR, Bunting S, Miller OV. 1977; Modulation of human platelet adenylate cyclase by prostacyclin (PGX). Prostaglandins 13: 377
    CrossrefPubMedSearch in Google Scholar
  • 3 Moncada S, Gryglewski RJ, Bunting S, Vane JR. 1976; An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature (London) 263: 663
    CrossrefPubMedSearch in Google Scholar
  • 4 Gryglewski RJ, Bunting S, Moncada S, Flower RJ, Vane RJ. 1976; Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. Prostaglandins 12: 685
    CrossrefPubMedSearch in Google Scholar